Add business listing!×
×
A medical director’s agreement, a treatment protocol, and a patient’s signed consent each serve a purpose. None automatically replaces the prescribing or treatment authorization required for an individual patient.
A medical director’s agreement, a treatment protocol, and a patient’s signed consent each serve a purpose. None automatically replaces the prescribing or treatment authorization required for an individual patient. For U.S. med spas in 2026, patient-specific prescribing requires attention to state law, professional scope of practice, the treatment involved, and how the patient is evaluated. There is no single nationwide rule covering every aesthetic service. Understanding how prescriptions, patient-specific orders, and clinical evaluations work together can help clinics build clearer workflows and reduce gaps in treatment authorization.
A patient-specific prescription is an authorized prescriber’s instruction for medication intended for an identified individual. It reflects a clinical decision about that patient’s treatment. A patient-specific order, or PSO, is a broader concept. It may authorize medication administration, a procedure, or another medical intervention for a named patient. Depending on its content and applicable law, an order may also function as a prescription.
These terms should not be treated as universally interchangeable:
| Document or process | Primary purpose |
|---|---|
| Prescription | Directs medication dispensing or use for an identified patient |
| Patient-specific order | Authorizes a particular patient’s medical treatment |
| Clinical evaluation | Establishes the medical basis for a treatment decision |
| Treatment protocol | Describes how a service should be performed |
| Informed consent | Documents the patient’s agreement after discussion of relevant information |
Clinics should confirm which documents their services require and whether their records satisfy the applicable legal standards.
Prescription medications, including botulinum toxin products and prescription weight-management drugs, require appropriate prescribing authority. Other aesthetic services may involve prescription devices, medical procedures, or delegated treatment requirements. Clinics should assess each service separately rather than assume every injectable or cosmetic treatment follows the same rules.
Purchasing a product for clinic inventory is also different from authorizing its use on a particular patient. Having medication available does not establish that an individual has been evaluated or that another clinician may administer it.
The professional must have legal authority for the particular medication or treatment in the relevant jurisdiction. Physicians, nurse practitioners, and physician assistants may have prescribing or ordering authority, subject to state licensing, scope-of-practice, and any applicable collaboration, supervision, or delegation requirements.
A registered nursing license alone does not confer independent prescribing authority. Similarly, aesthetic training or an injection certification does not expand a professional’s statutory scope of practice. Clinics need to verify both sides of the workflow: who may authorize treatment and who may perform it.
A standing order generally applies to a defined patient population under specified conditions. Its legality and permitted uses depend on state law. New York’s September 2026 nursing guidance states that, in most cases, registered nurses administer medical regimens ordered for a specific patient by a qualified practitioner who has examined that patient. The state permits non-patient-specific orders for designated services, including certain immunizations, testing, and emergency treatments.
Those exceptions should not be interpreted as blanket permission to administer elective aesthetic treatments under a general protocol. For a med spa, the practical question is whether the relevant jurisdiction permits the proposed standing-order arrangement for the exact service and professionals involved.
No. A clinical evaluation and a prescribing decision are related but distinct. An evaluation-often called a Good Faith Exam in the aesthetics industry-helps establish whether a proposed treatment is appropriate. A prescription or order records the authorized treatment instructions. The evaluation and order may appear in the same encounter record. What matters is whether the documentation contains the required assessment, clinical decision, and authorization.
California, for example, requires an appropriate prior examination and medical indication for prescribing covered drugs, subject to statutory exceptions. A generic “cleared for treatment” statement should not be assumed to provide every instruction required for medication administration.
Telehealth may support patient evaluation and prescribing when the applicable laws and clinical circumstances permit it. Providers must hold the appropriate license or other legal authorization for the state where the patient is located. Clinics also need to check requirements governing examination methods, consent, prescribing, and any mandatory in-person care. A questionnaire, video consultation, and in-person examination are different assessment methods. Their suitability depends on the governing rules and whether the provider can obtain enough information to meet the standard of care.
For clinics evaluating digital authorization workflows, Qualiphy’s patient-specific order services connect patients with licensed providers and support documented treatment decisions. Qualiphy describes its reports as including clinical rationale, treatment authorization, and prescribing details. Clinics should confirm that the selected workflow fits their state, treatment, and staffing arrangement.
A useful internal review should check whether the record clearly identifies:
This is an operational checklist, not a universal statutory minimum. Additional requirements may apply. Maintain administration records separately where appropriate, including what was actually given, by whom, and when. The authorization and the treatment delivered should be traceable within the patient record.
Yes. Federal compounding requirements operate alongside state prescribing and pharmacy laws. Section 503A generally ties qualifying compounded drugs to prescriptions for identified individual patients, with limited anticipatory compounding permitted under specified conditions.
Section 503B allows qualifying outsourcing facilities to supply certain compounded drugs without first obtaining individual patient prescriptions, subject to federal requirements. That distinction does not remove applicable patient evaluation, prescribing, administration, or state-law obligations. Clinics should verify the supplier’s status and the permitted use of the product rather than assume all compounded medications can be purchased as unrestricted office stock.
Map each service from evaluation through authorization, administration, and follow-up. Confirm who is responsible at every step and when a changed treatment plan or health condition requires renewed clinical review. Have healthcare counsel and clinical leadership review state-specific requirements before adding services or locations. Clear, patient-specific documentation should connect the clinical assessment to the treatment actually delivered.
This article provides general educational information and is not legal or medical advice. Requirements vary by state, professional license, medication, and procedure.
Business Directory
For Business Owners
Popular categories